EI
JNP

EAM Investors’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

EAM Investors’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-146,475
Closed -$1.51M – 392
2015
Q4 		$1.51M Buy
146,475
+577
+0.4% +$6.69K 0.2% 204
2015
Q3 		$1.72M Buy
+145,898
New +$1.61M 0.27% 174

Other funds holding JNP

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

EAM Investors's JNP Position: Q1 2016 in Review

EAM Investors sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q1 2016, closing a stake of 146,475 shares — an estimated $1.51M sold.

EAM Investors first reported a position in JNP in Q3 2015 and held it in 2 quarters. The position peaked at $1.72M in Q3 2015. 50 funds tracked by Wall St. Rank hold JNP as of Q1 2016.

  • EAM Investors reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • EAM Investors sold 146,475 Juniper Pharmaceuticals, Inc. Common Stock shares in Q1 2016, an estimated $1.51M.
  • EAM Investors first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2015 and held it in 2 quarters.
  • EAM Investors's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $1.72M in Q3 2015.
  • 50 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q1 2016.

Based on EAM Investors's 13F filing for Q1 2016, filed 16 May 2016.